| Market Cap | 2.78B | P/E | 7.69 | EPS this Y | 16.70% | Ern Qtrly Grth | -3.30% |
| Income | 986.71M | Forward P/E | 15.38 | EPS next Y | 23.80% | 50D Avg Chg | 8.00% |
| Sales | 8.22B | PEG | - | EPS past 5Y | 9.10% | 200D Avg Chg | 27.00% |
| Dividend | 23.00% | Price/Book | 0.16 | EPS next 5Y | - | 52W High Chg | -6.00% |
| Recommedations | - | Quick Ratio | 1.51 | Shares Outstanding | 200M | 52W Low Chg | 64.00% |
| Insider Own | 8.62% | ROA | 4.90% | Shares Float | 426.87M | Beta | 0.70 |
| Inst Own | 0.09% | ROE | 14.68% | Shares Shorted/Prior | -/- | Price | 1.23 |
| Gross Margin | 43.66% | Profit Margin | 12.00% | Avg. Volume | 633,776 | Target Price | - |
| Oper. Margin | 2.69% | Earnings Date | Apr 29 | Volume | 170,200 | Change | -4.65% |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was founded in 1981 and is based in Tianjin, the People's Republic of China.